Tag: Atrial Fibrillation
Net Benefit of Anticoagulants for A-Fib Varies With Stroke Rate
Benefit of warfarin anticoagulation varies with varying published stroke rates
Perspectives on USPSTF A-Fib Screening Recommendation
Physicians weigh in on the need to develop a screening strategy
USPSTF: Insufficient Evidence to Screen for Atrial Fibrillation
U.S. Preventive Services Task Force says benefit unclear in asymptomatic, older patients
Immediate Monitoring With ECG Patch Ups A-Fib Diagnosis Rate
Immediate versus delayed monitoring results in increased a-fib diagnosis rate in high-risk individuals
Asthma, Uncontrolled Asthma Associated With Risk of A-Fib
Dose-response association seen between levels of asthma control and risk of atrial fibrillation
Weight Loss Linked to Reversal of Atrial Fibrillation Progression
Increased weight loss with risk factor management associated with greater atrial fibrillation freedom
Variation in Quality of Trials for Atrial Fibrillation, Flutter
Most common trial endpoint is AF/AFL recurrence; rates of primary clinical endpoints are low
Sleep Disruption Increases Risk of Atrial Fibrillation
Higher risk seen across multiple cohorts, regardless of obstructive sleep apnea and other possible factors
Hyoscyamine Helps in A-Fib With Slow Ventricular Response
Successful response in patient with comorbidities who was a poor candidate for pacemaker placement
Nut Consumption Associated With Reduced Risk of A-Fib
Possible correlation also seen for nut consumption with reduced risk of heart failure
